Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Bruce S. Schneider"'
Autor:
Bruce S. Schneider, Evgenij Evdokimov, Larisa Rudenko, Cheng-Hong Wei, Phillip J. Snoy, Allen K. Wensky, Jeff Jones, Judith Arcidiacono, Mark H. Lee, Keith Wonnacott
Publikováno v:
Xenotransplantation. 17:329-337
The use of xenogeneic porcine pancreatic islets has been shown to be a potentially promising alternative to using human allogeneic islets to treat insulin-dependent type 1 diabetes (T1D). This article provides an overview of the existing FDA regulato
Publikováno v:
Trends in Biotechnology. 31:665-667
The number of investigational knee cartilage repair or replacement product submissions (hereafter referred to as cartilage products) received by the FDA is increasing. This trend may reflect the rise in cartilage repair publications and active produc
Publikováno v:
Pharmacotherapy. 23:735-744
Study Objective. To explore the clinical characteristics of hyperglycemia in patients treated with risperidone. Design. Pharmacovigilance survey of spontaneously reported adverse events in risperidone-treated patients, with reports of haloperidol-ass
Autor:
Violet Woo, Pamela Starke-Reed, William H. Dietz, Kathryn Y McMurry, Bruce S. Schneider, Allan S. Noonan, Yvonne Jackson, Wendy L. Johnson-Taylor, John J. Whyte, Lloyd J. Kolbe, Kathy McCarty, Howell Wechsler, Van S. Hubbard, Christine B. Spain, Laura A. McNally, Richard P. Troiano, Jean Charles-Azure, Randolph F. Wykoff, Martina Vogel-Taylor, Charlene Sanders, Susan Z. Yanovski, Karen A. Donato, Jonelle Rowe, Robert J. Kuczmarski, Lynne Haverkos
Publikováno v:
Scopus-Elsevier
Objective: To provide insight into discussions at the Surgeon General's Listening Session, “Toward a National Action Plan on Overweight and Obesity,” and to complement The Surgeon General's Call to Action to Prevent and Decrease Overweight and Ob
Autor:
Bruce S. Schneider, Charles L. Zimliki, Ilan Irony, Arleen Pinkos, Hylton V. Joffe, Guillermo Arreaza-Rubin, William J. Heetderks
Publikováno v:
Drug discovery today. Technologies. 4(1)
One of the critical path initiatives of the Food and Drug Administration (FDA) is to accelerate the development and availability of a safe and effective artificial pancreas for the treatment of diabetes mellitus. The FDA has established a multidiscip
Autor:
Celia Witten, Patrick Au, Deborah A. Hursh, Steven S. Oh, Agnes Lim, Bruce S. Schneider, Malcolm Moos
Publikováno v:
Science Translational Medicine. 4
U.S. Food and Drug Administration applies regulatory flexibility to balance benefits and risks to subjects in cell-therapy clinical trials.
Publikováno v:
Surgical Neurology. 36:40-43
A 27-year-old woman presented to our institution in her seventh month of pregnancy with complaints of headache and visual field disturbance. Workup revealed bitemporal hemianopia, a markedly enlarged pituitary gland on computed tomography scan, and b
Autor:
David J. Gross, E M Bailyes, Erol Cerasi, Nurit Kaiser, Donald F. Steiner, John C. Hutton, Bruce S Schneider
Publikováno v:
Diabetes. 46(6)
Psammomys obesus fed a high-calorie diet develops a NIDDM-like syndrome. The use of reverse-phase highperformance liquid chromatography (HPLC) to study Psammomys insulin biosynthesis and release revealed a very delayed elution time for the Psammomys
Publikováno v:
Proceedings. Biological sciences. 263(1366)
In a previous report we quantified the apparently complex and irregular distribution of pancreatic islets in the guinea pig by showing that they formed a set of cluster or correlation dimension approximately 2.5. Here we show that this distribution h
Autor:
K. Gorray, Guy Maytal, Micheline A. Schreiber, J. Maimon, Harold M. Hastings, Bruce S. Schneider
Publikováno v:
Proceedings. Biological sciences. 250(1329)
Quantitative histomorphometric studies of the dynamics of growth and development of pancreatic islets in normal and pathological states pose substantial methodological and conceptual problems. We address these problems with the geometry of random fra